ProPhase Labs Inc. (NASDAQ: PRPH) Stock Information | RedChip

ProPhase Labs Inc. NASDAQ: PRPH logo small-cap


$4.71 -0.20 ( -4.04% ) 60.0K

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

Investor Presentation

Investor Presentation




*By entering your information you agree to our privacy policy.

Specialist Info


Barrett Boone

barrett@redchip.com

407-571-0912